该制剂含有甲磺酸多沙唑嗪和药学上可接受的聚合物。
The preparation contains doxazosin mesylate and polymer which is acceptable in pharmacy.
本发明提供了一种甲磺酸多沙唑嗪双层渗透泵控释片。
The invention provides a doxazosin mesylate bi-layer osmotic pump controlled release tablet.
结论：甲磺酸多沙唑嗪片降压作用稳定，患者依从性较好。
Conclusion: Doxazosin has stable hypotensive effect and the patients compliance is good.
目的：在健康志愿受试者中评价单次口服国产甲磺酸多沙唑嗪的安全性和耐受性。
OBJECTIVE: Single oral dose study was performed to assess the safety and toleration of domestic doxazosin mesylate in healthy volunteers.
结论甲磺酸多沙唑嗪片与盐酸特拉唑嗪片疗效相似，是治疗轻中度原发性高血压安全、有效的药物。
Conclusions Both doxazosin and terazosin were effective and safe for the treatment of mild and moderate primary hypertension.
结论甲磺酸多沙唑嗪片与盐酸特拉唑嗪片疗效相似，是治疗轻中度原发性高血压安全、有效的药物。
Conclusions Both doxazosin and terazosin were effective and safe for the treatment of mild and moderate primary hypertension.
应用推荐